These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21626811)

  • 21. [Advantages of ramipril/amlodipin fixed combination therapy. When should we use it?].
    Simonyi G
    Orv Hetil; 2013 Oct; 154(42):1658-64. PubMed ID: 24121218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluating the effectiveness of a fixed combination of amlodipine and bisoprolol in ambulatory patients with arterial hypertension and ischemic heart disease].
    Chesnikova AI; Safronenko VA; Kolomatskaia OE
    Kardiologiia; 2014; 54(9):17-23. PubMed ID: 25702398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [24-Hour blood pressure profiles in brachial artery and the aorta: correlation and effects of fixed combination of amlodipine and lisinopril].
    Kobalava ZhD; Kotovskaia IuV; Semagina IM; Bogomaz AV
    Kardiologiia; 2014; 54(10):13-8. PubMed ID: 25675715
    [No Abstract]   [Full Text] [Related]  

  • 24. Double-blind crossover study of the interaction between perindopril and amlodipine on blood pressure and hormones related to fluid and electrolyte balance in patients with essential hypertension.
    Stokes GS; Monaghan JC; Berman K; Ryan M; Campbell DJ
    J Hum Hypertens; 1998 Feb; 12(2):129-34. PubMed ID: 9504354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficiency perindopril at patients with arterial hypertension and obesity].
    Nedogoda SV; Lediaeva AA; Chumachok EV; Tsoma VV; Mazina GG; Salasiuk AS
    Kardiologiia; 2011; 51(11):38-44. PubMed ID: 22117769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
    Schmieder RE
    Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
    Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
    J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of fixed-dose combination of perindopril A/amlodipine on inter visit-to-visit and inter visit blood pressure and heart rate variability in real clinical practice in the Russian observation program KONSTANTA].
    Kobalava ZhD; Kotovskaia IuV; Troitskaia EA; Luk'ianova EA; Dmitrova TB
    Kardiologiia; 2014; 54(1):34-40. PubMed ID: 24881309
    [No Abstract]   [Full Text] [Related]  

  • 30. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined therapy of arterial hypertension with the fixed combination of perindopril arginine / amlodipine in real clinical practice: the organization and the main results of the program CONSTANTA].
    Kobalava ZhD; Kotovskaia IuV; Luk'ianova EA
    Kardiologiia; 2013; 53(6):25-34. PubMed ID: 23953042
    [No Abstract]   [Full Text] [Related]  

  • 32. Perindopril arginine and amlodipine besylate for hypertension: a safety evaluation.
    Elliott WJ; Bistrika EA
    Expert Opin Drug Saf; 2018 Feb; 17(2):207-216. PubMed ID: 29065722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ; Ferrari R; Simoons ML
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Optimization of the control of blood pressure. What contribution can be obtained from use of combinations of fixed doses of ace inhibitors and calcium channel blockers?].
    Eliseev OM
    Ter Arkh; 2011; 83(5):70-5. PubMed ID: 21780662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
    Karpov IuA
    Kardiologiia; 2005; 45(12):87-92. PubMed ID: 16353053
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.
    Fujita T; Ando K; Nishimura H; Ideura T; Yasuda G; Isshiki M; Takahashi K;
    Kidney Int; 2007 Dec; 72(12):1543-9. PubMed ID: 17943080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [EFFECTIVENESS OF FIXED COMBINATION OF PERINDOPRILARGININE AND AMLODIPINE FOR THE TREATMENT OF ARTERIAL HYPERTENSION WITH CONCOMITANT CHRONIC CARDIAC INSUFFICIENCY AND SIGNS OF CHRONIC KIDNEY DISEASE].
    Kuznetsova TE; Borovkova NY
    Klin Med (Mosk); 2015; 93(7):62-6. PubMed ID: 26596062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials.
    Lv Y; Zou Z; Chen GM; Jia HX; Zhong J; Fang WW
    Blood Press Monit; 2010 Aug; 15(4):195-204. PubMed ID: 20512032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.